Detalhe da pesquisa
1.
COX-1 and COX-2 contribute differentially to the LPS-induced release of PGE2 and TxA2 in liver macrophages.
Prostaglandins Other Lipid Mediat
; 79(1-2): 93-100, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16516813
2.
Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study.
Transplantation
; 75(7): 977-82, 2003 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12698083
3.
Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study.
Eur J Gastroenterol Hepatol
; 14(2): 153-8, 2002 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-11981339
4.
The regulatory role of prostaglandin E2 in liver (patho) physiology is controlled at its site of synthesis and its action on the receptors.
Comp Hepatol
; 3 Suppl 1: S35, 2004 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-14960187
5.
[What are the indications for treatment of acute hepatitis C?]. / Quelles sont les indications du traitement dans l'hépatite C aiguë?
Gastroenterol Clin Biol
; 26 Spec No 2: B188-93, 2002 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-12180287
6.
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study.
Gastroenterology
; 122(4): 923-30, 2002 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-11910344